{"id":"tedivax-adult-td-rix","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain/tenderness"},{"rate":null,"effect":"Injection site erythema/swelling"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL430074","moleculeType":"Small molecule","molecularWeight":"1769.69"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated toxins from Clostridium tetani and Corynebacterium diphtheriae, which trigger adaptive immune responses without causing disease. These toxoids prime B cells and T cells to recognize and neutralize the actual toxins if exposure occurs, providing long-term protective immunity against tetanus and diphtheria.","oneSentence":"Tedivax-Adult/Td-Rix is a combined tetanus and diphtheria toxoid vaccine that stimulates the immune system to produce antibodies against tetanus and diphtheria toxins.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:45.251Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Active immunization against tetanus and diphtheria in adults"},{"name":"Booster vaccination in adults with prior tetanus/diphtheria immunization"}]},"trialDetails":[{"nctId":"NCT01262924","phase":"PHASE3","title":"Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"1997-10","conditions":"Diphteria, Tetanus and Pertussis","enrollment":116}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tedivax-Adult™/ Td-Rix™","genericName":"Tedivax-Adult™/ Td-Rix™","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Biologic","firstApprovalDate":"","aiSummary":"Tedivax-Adult/Td-Rix is a combined tetanus and diphtheria toxoid vaccine that stimulates the immune system to produce antibodies against tetanus and diphtheria toxins. Used for Active immunization against tetanus and diphtheria in adults, Booster vaccination in adults with prior tetanus/diphtheria immunization.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}